Search

everythinglearnresearchcommunity

for

Search:↓

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Women are more likely to have long-term post-COVID symptoms than men.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Finasteride treats hair loss and reduces prostate cancer risk.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Older men and those with a history of skin cancer have a higher risk of getting skin cancer again.

PCOS increases the risk of heart disease and type 2 diabetes in women.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Some chemicals absorbed through the skin can cause serious health problems.